CRBP – corbus pharmaceuticals holdings, inc. (US:NASDAQ)

DELAYED
$ usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day CRBP SPY QQQ SPX
Date
Time
Symbol
Company Name
Action
%Chg
11/12/2025
08:00 am
crbp
corbus pharmaceuticals holdings, inc.
MISS
9.7%
8/5/2025
08:00 am
crbp
corbus pharmaceuticals holdings, inc.
BEAT
-3.1%
5/6/2025
08:00 am
crbp
corbus pharmaceuticals holdings, inc.
MISS
-16.2%
3/11/2025
08:00 am
crbp
corbus pharmaceuticals holdings, inc.
BEAT
-2.1%
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions?
The answers are right here.
Date
Time
Action
From
To
Firm
Impact
%Chg
details
Stock Stats
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Top News Gainers
3/16 Form 10-K Corbus Pharmaceuticals For: Dec 31 23.8%
3/26 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) is now covered by analysts at Nomura. They set a "buy" rating and a $112.00 price target on the stock. 12.7%
3/12 Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q4 2019 Earnings Call Transcript [The Motley Fool] 11.8%
3/18 Form 4 Corbus Pharmaceuticals For: Mar 17 Filed by: Millian Craig Stuart 10.0%
3/9 Form 4 Corbus Pharmaceuticals For: Mar 06 Filed by: Moran Sean F. 9.6%
3/18 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 9.3%
4/9 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 8.7%
5/10 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock. 5.2%
3/28 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 5.0%
1/14 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 4.8%
Top News Decliners
12/9 Corbus Pharmaceuticals to Host Expert Symposium on the Therapeutic Potential of Targeting the Endocannabinoid System -9.1%
5/9 Q1/2019 3/31/2019 EPS -0.430 ZacksConsensus 0.020 ActVsEst (0.450) - Miss -8.9%
8/8 Form 8-K Corbus Pharmaceuticals For: Aug 08 -8.7%
2/26 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $5.75 price target on the stock. -8.5%
11/7 Q3/2019 9/30/2019 EPS -0.320 ZacksConsensus -0.360 ActVsEst 0.040 - Beat -8.0%
3/12 Q4/2019 12/31/2019 EPS -0.410 ZacksConsensus -0.340 ActVsEst (0.070) - Miss -7.3%
3/10 Form 4 Corbus Pharmaceuticals For: Mar 06 Filed by: Salzmann Peter -6.8%
2/6 Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock -6.4%
8/13 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $7.00 price target on the stock. -6.2%
3/5 Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2019 Results on March 12, 2020 -6.1%

Don’t Miss Out On The Next BIG Stock Move

Thanks for submitting the form.
CRBP – corbus pharmaceuticals holdings, inc. (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
CRBP
SPY
QQQ
SPX
CRBP – corbus pharmaceuticals holdings, inc. (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
CRBP SPY QQQ SPX
Stock Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Stock Stats
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
News
2/26
03:27 am
crbp
Medium
Corbus Pharmaceuticals Touts “Catalyst-Rich” 2026 With CRB-701 and CRB-913 Data Readouts Ahead [Yahoo! Finance]
2/19
07:26 am
crbp
Medium
Corbus Pharmaceuticals (NASDAQ:CRBP) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
2/12
08:29 am
crbp
Medium
Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference [Yahoo! Finance]
2/12
08:00 am
crbp
Medium
Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference
2/6
06:06 pm
crbp
Low
Corbus Pharmaceuticals: Maintaining 'Hold' As Summer 2026 Obesity Data Catalyst Looms [Seeking Alpha]
1/5
07:37 am
crbp
Low
Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/5
07:30 am
crbp
Low
Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/27
09:12 am
crbp
Low
While hedge funds own 24% of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), retail investors are its largest shareholders with 46% ownership [Yahoo! Finance]
12/11
04:48 pm
crbp
Medium
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Phase 1a Single-Ascending and Multiple-Ascending Dose Data Transcript [Seeking Alpha]
11/12/2025
08:00 am
crbp
9.7%
MISS
8/5/2025
08:00 am
crbp
-3.1%
BEAT
5/6/2025
08:00 am
crbp
-16.2%
MISS
3/11/2025
08:00 am
crbp
-2.1%
BEAT
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions? The answers are right here.
3/4
04:30 pm
crbp
Medium
Form 4 Corbus Pharmaceuticals For: Mar 02 Filed by: Smethurst Dominic
3/2
04:08 pm
crbp
Low
Form 144 Corbus Pharmaceuticals Filed by: Smethurst Dominic
2/25
07:46 am
crbp
Low
Form 8-K Corbus Pharmaceuticals For: Feb 25
2/18
04:32 pm
crbp
Medium
Form 4 Corbus Pharmaceuticals For: Feb 17 Filed by: Hodgson Ian
2/18
04:31 pm
crbp
Medium
Form 4 Corbus Pharmaceuticals For: Feb 13 Filed by: Moran Sean F.
2/18
04:30 pm
crbp
Medium
Form 4 Corbus Pharmaceuticals For: Feb 13 Filed by: Cohen Yuval
2/13
04:03 pm
crbp
Low
Form 144 Corbus Pharmaceuticals Filed by: Cohen Yuval
2/10
01:15 pm
crbp
Low
Form SCHEDULE 13G/A Corbus Pharmaceuticals Filed by: Octagon Capital Advisors LP
2/4
04:26 pm
crbp
Medium
Form 4 Corbus Pharmaceuticals For: Feb 03 Filed by: Smethurst Dominic
Show more
Top News Gainers
3/16 Form 10-K Corbus Pharmaceuticals For: Dec 31 23.8%
3/26 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) is now covered by analysts at Nomura. They set a "buy" rating and a $112.00 price target on the stock. 12.7%
3/12 Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q4 2019 Earnings Call Transcript [The Motley Fool] 11.8%
3/18 Form 4 Corbus Pharmaceuticals For: Mar 17 Filed by: Millian Craig Stuart 10.0%
3/9 Form 4 Corbus Pharmaceuticals For: Mar 06 Filed by: Moran Sean F. 9.6%
3/18 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 9.3%
4/9 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 8.7%
5/10 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock. 5.2%
3/28 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 5.0%
1/14 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 4.8%
Top News Decliners
12/9 Corbus Pharmaceuticals to Host Expert Symposium on the Therapeutic Potential of Targeting the Endocannabinoid System -9.1%
5/9 Q1/2019 3/31/2019 EPS -0.430 ZacksConsensus 0.020 ActVsEst (0.450) - Miss -8.9%
8/8 Form 8-K Corbus Pharmaceuticals For: Aug 08 -8.7%
2/26 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $5.75 price target on the stock. -8.5%
11/7 Q3/2019 9/30/2019 EPS -0.320 ZacksConsensus -0.360 ActVsEst 0.040 - Beat -8.0%
3/12 Q4/2019 12/31/2019 EPS -0.410 ZacksConsensus -0.340 ActVsEst (0.070) - Miss -7.3%
3/10 Form 4 Corbus Pharmaceuticals For: Mar 06 Filed by: Salzmann Peter -6.8%
2/6 Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock -6.4%
8/13 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $7.00 price target on the stock. -6.2%
3/5 Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2019 Results on March 12, 2020 -6.1%